Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®


Randomized study evaluating the efficacy and safety of switching from an an abacavir/lamivudine-based regimen to an elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide single-tablet regimen

Rizzardini, Giulianoa,b; Gori, Andreac; Miralles, Celiad; Olalla, Juliáne; Molina, Jean-Michelf; Raffi, Françoisg; Kumar, Princyh; Antinori, Andreai; Ramgopal, Motij; Stellbrink, Hans-Jürgenk; Das, Moupalil; Chu, Hoal; Ram, Reneel; Garner, Willl; Shao, Yongwul; Chuck, Susan K.l; Piontkowsky, Davidl; Haubrich, Richard H.l

Author Information
doi: 10.1097/QAD.0000000000002244
  • Buy
  • SDC


Copyright © 2019 Wolters Kluwer Health, Inc.